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associated with two main purposes: as structural compo-
nents of membranes (bulk function) and as precursors to 
signaling molecules that regulate growth and development 
(sparking function). The sterol biosynthetic pathways en-
compass phylum-specifi c branches that yield distinctive end 
products. Cholesterol is the most abundant sterol in verte-
brates, where it is an essential component of cell membranes 
and acts as a precursor to vitamin D and steroid hormones. 
Invertebrates such as  Caenorhabditis elegans or  Drosophila mel-
anogaster are sterol auxotrophs that rely on uptake of exog-
enous sterols ( 1–3 ). Fungi synthesize ergosterol, which has 
a greater degree of unsaturation than cholesterol and an 
additional methyl group at C-24. Plants make a large variety 
of phytosterols, such as the 24-alkylated campesterol, sitos-
terol, or stigmasterol. Sterol diversity may be equally high in 
the protozoa, involving cholesterol and stigmasterol in  Para-
mecium ( 4 ), ergosterol and stigmasterols in  Acanthamoeba 
( 5 ), cycloartenol and cyclolaudenol in  Dicytostelium ( 6 ), and 
ergosterol in trypanosomatids ( 7, 8 ). 
 The sterol biosynthetic pathways involve more than 40 
enzymes ( Table 1 ).  Isopentenyl diphosphate, the building 
block of isoprenoids, is made either from acetyl-CoA via 
the MEV pathway or from pyruvate plus glyceraldehyde 
3-phosphate via the deoxyxylulose 5-phosphate (DOXP) 
pathway ( Fig. 1 ).  The condensation of two molecules of 
farnesyl diphosphate to produce squalene is the commit-
ting step of sterol synthesis. From there, the synthesis pro-
ceeds via lanosterol and zymosterol to cholesterol and 
ergosterol derivatives, or via cycloartenol to the various 
kinds of phytosterols ( Fig. 1 ). The enzymes that mediate 
sterol biosynthesis are of dual interest: First, there is 
a pharmacological interest because sterol biosynthesis 
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because the evolution of eukaryotes is thought to be inter-
linked with that of the sterols ( 21 ). 
 Here we present an in silico pipeline for comparative 
genomics of eukaryotes based on prediction of sterol bio-
synthetic enzymes. Our aim is to shed light on the evolu-
tionary relationships of these enzymes and to identify new 
antiparasitic drug target candidates. Focusing on trypano-
somatids, we further compare the stage-specifi city of ex-
pression of the sterol biosynthetic enzymes, and we probe 
the potential of selected SBIs against a panel of parasites. 
 MATERIALS AND METHODS 
 Sequences 
 Proteome fi les were downloaded from Uniprot ( 22 ), Eu-
PathDB ( 23 ), and Integr8 ( 24 ). The predicted proteomes were 
tested for completeness against the 100 most conserved pro-
teins of the Core Eukaryotic Genes Mapping Approach data-
base ( 25 ), which we had determined based on HMMer 3.0 profi le 
( 26, 27 ) searches of eukaryote reference proteomes ( C. elegans , 
inhibitors (SBIs) are widely deployed as chemotherapeu-
tics. As indicated in  Fig. 1 , human HMG-CoA reductase 
serves as the target of cholesterol-lowering statins such as 
simvastatin ( 9 ). Human farnesyl diphosphate synthase is 
the target of bisphosphonates (e.g., tiludronate), used 
against osteoporosis ( 10 ). Squalene epoxidase and sterol 
24-methyltransferase are antifungal targets, inhibited by 
allylamines (e.g., terbinafi ne) and azasterols, respectively 
( 11–14 ). A particularly promising target is sterol 14-dem-
ethylase (CYP51). Azole inhibitors of CYP51 (e.g., keto-
conazole) are widely used for fungal infections and, 
because trypanosomatid parasites also make ergosterol 
( 15–17 ), lend themselves for a piggyback approach toward 
the urgently required new drugs for Chagas’s disease. The 
latest antifungal approved by the U.S. Food and Drug Ad-
ministration, posaconazole, was shown to be highly active 
against  Trypanosoma cruzi in culture and in vivo ( 18–20 ), 
and it is currently undergoing phase 2 clinical trials for the 
treatment of Chagas’s disease. Second, sterol biosynthetic 
enzymes are of phylogenetic importance. Sterols were pro-
posed to hold a key to understanding eukaryote phylogeny 
 TABLE 1. Sterol biosynthetic enzymes 
# EC KEGG Enzyme Name
1 2.3.1.9 K00626 Acetyl-CoA C-acetyltransferase
2 2.3.3.10 K01641 Hydroxymethylglutaryl-CoA synthase
3 1.1.1.34 K00021 Hydroxymethylglutaryl-CoA reductase (NADPH)
4 1.1.1.88 K00054 Hydroxymethylglutaryl-CoA reductase
5 2.7.1.36 K00869 Mevalonate (MEV) kinase
6 2.7.4.2 K00938 Phospho-MEV kinase
7 4.1.1.33 K01597 Diphospho-MEV decarboxylase
8 2.2.1.7 K01662 1-Deoxy- D -xylulose-5-phosphate synthase
9 1.1.1.267 K00099 1-Deoxy- D -xylulose-5-phosphate reductoisomerase
10 2.7.7.60 K00991 2-C-methyl- D -erythritol 4-phosphate cytidylyltransferase
11 2.7.1.148 K00919 4-Diphosphocytidyl-2-C-methyl- D -erythritol kinase
12 4.6.1.12 K01770 2-C-methyl- D -erythritol 2,4-cyclodiphosphate synthase
13 1.17.7.1 K03526 ( E )-4-hydroxy-3-methylbut-2-enyl-diphosphate synthase
14 1.17.1.2 K03527 4-Hydroxy-3-methylbut-2-enyl diphosphate reductase
15 5.3.3.2 K01823 Isopentenyl-diphosphate delta-isomerase
16 4.2.3.27 K12742 Isoprene synthase
17 2.5.1.1 K00787 Geranyl diphosphate synthase
18 2.5.1.68 K12503 Short-chain  Z -isoprenyl diphosphate synthase
19 2.5.1.86 K14215  Trans ,poly cis -decaprenyl diphosphate synthase
20 2.5.1.10 K00787 Farnesyl diphosphate synthase
21 2.5.1.21 K00801 Farnesyl-diphosphate farnesyltransferase
22 1.14.13.132 K00511 Squalene monooxygenase
23 5.4.99.7 K01852 Lanosterol synthase
24 1.14.13.70 K05917 Cytochrome P450, family 51 (CYP51; sterol 14-demethylase)
25 1.3.1.70 K00222 Delta14-sterol reductase
26 1.14.13.72 K07750 Methylsterol monooxygenase
27 1.1.1.170 K07748 Sterol-4  -carboxylate 3-dehydrogenase (decarboxylating)
28 1.1.1.270 K09827 3-Keto steroid reductase
29 5.3.3.5 K01824 Cholestenol delta-isomerase
30 1.3.1.72 K09828 Delta24-sterol reductase
31 1.14.21.6 K00227 Lathosterol oxidase
32 1.3.1.21 K00213 7-Dehydrocholesterol reductase
33 3.1.1.13 K01052 Lysosomal acid lipase/cholesteryl ester hydrolase
34 2.3.1.26 K00637 Sterol  O -acyltransferase
35 1.14.13.13 K07438 Calcidiol 1-monooxygenase
36 1.14.13.126 K07436 Vitamin D3 24-hydroxylase
37 2.1.1.41 K00559 Sterol 24-C-methyltransferase
38 5.-.-.- K09829 C-8 sterol isomerase
39 1.3.1.71 K00223 Delta24[24 (1)]-sterol reductase
40 5.4.99.8 K01853 Cycloartenol synthase
41 2.1.1.143 K08242 24-Methylenesterol C-methyltransferase
42 n.a. K09832 Cytochrome P450, family 710, subfamily A
EC, Enzyme Commission number; KEGG , Kyoto Encyclopedia of Genes and Genomes identifi er.
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purchased from Sigma-Aldrich (R7017-1G), and Chlorophenol 
red galactopyranoside (CPRG) from Roche (10884308001). 
 Cell lines 
 The cell lines used for in vitro drug sensitivity determination 
were rat L6 myoblasts,  T. brucei rhodesiense STIB 900,  T. cruzi Tula-
huen C2C4 (expressing  Escherichia coli   -galactosidase),  Leishma-
nia donovani MHOM-ET-67/L82 axenic amastigotes,  Giardia 
intestinalis strain G1, and  P. falciparum strain K1. 
 Bioinformatics 
 Multiple alignments were performed with ClustalW 2.0.10 
( 29 ). All profi le constructions and searches were carried out with 
HMMer 3.0 ( 26 ). The heat map was produced with the R library 
 gplots ( 30 ). Hierarchical clustering was performed with the R li-
brary  Pvclust , using Canberra distance and the McQuitty algo-
rithm ( 31 ). Pvclust assesses uncertainty in hierarchical cluster 
Chlamydomonas reinhardtii , D. discoideum , D. melanogaster , D. rerio , 
E. cuniculi , Entamoeba histolytica , G. lamblia , Homo sapiens , K. lactis , 
L. major , M. musculus , Plasmodium falciparum , S. cerevisiae , S. pombe , 
Trypanosoma brucei , T. cruzi , T. parva ,  and  T. vaginalis ). Additional 
proteomes were included only if  hmmscan of HMMer 3.0 returned 
a hit for at least 99 profi les with an expectancy ( E ) value   10   30 . 
Redundancy-reduced sets of reference sequences for the enzymes 
of interest ( Table 1 ) were downloaded from UniRef90 ( 28 ). 
 Chemicals 
 Simvastatin (S6196-25MG), tiludronate disodium salt hydrate 
(T4580-10MG), terbinafi ne hydrochloride (T8826-100MG), and 
ketoconazole (K1003-100MG) were purchased from Sigma-Aldrich. 
Fenpropimorph was kindly offered by M. Witschel from BASF. The 
test compounds were dissolved in dimethyl sulfoxide at 10 mg/ml 
and stored at   20°C. Resazurin sodium salt (Alamar Blue) was 
 Fig.  1. Overview on sterol biosynthesis. Enzymes are represented by triangles, metabolites by circles. In-
hibitors are indicated in bold. Key metabolites are spelled out. See  Table 1 for enzyme name EC classifi ers. 
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 The known differences among the analyzed eukaryotes 
were obvious. The absence of the MEV pathway (enzyme 
nos. 2 to 7 of  Table 1 ) and the presence of the MEP /
DOXP pathway (enzyme nos. 8 to 14) were apparent in 
most apicomplexan species, with the exception of  Cryp-
tosporidium parvum , which lacked either pathway ( Fig. 2 , 
top). This is in agreement with  C. parvum having lost the 
plastid genome in the course of evolution ( 38 ). It was in-
teresting to note that  E. histolytica was also defi cient in ei-
ther pathway, a fi nding that, to our knowledge, had not 
been reported before ( 39 ).  Entamoeba was reported to be 
capable of limited cholesterol synthesis ( 40 ). Our data, 
however, support earlier reports suggesting an absolute 
requirement for cholesterol by  Entamoeba ( 41 ). The vascu-
lar plants possessed both pathways, but the green algae  C. 
reinhardtii and  Ostreococcus tauri only had the MEP/DOXP 
arm, a fact that had been elegantly demonstrated for  C. 
reinhardtii and other green algae by feeding experiments 
with radiolabeled glucose ( 42 ). 
 As expected, the sterol 24-C-methyltransferases SMT1 
and SMT2 (enzyme nos. 37 and 41), characteristic of er-
gosterol synthesis, were absent in all vertebrates. The ge-
nome-wide screen also confi rmed the presence of a set 
of sterol synthetic enzymes, including 24-C-methyltrans-
ferases, in trypanosomatids. Surprisingly, though, the try-
panosomatids lacked sterol  O -acyltransferase as well as 
cholesteryl ester hydrolase (enzyme nos. 34 and 33, re-
spectively), and yet,  T. brucei had been shown to be capable 
of sterol esterifi cation ( 43 ), suggesting that trypanosoma-
tids might use unusual enzymes for ester synthesis and 
hydrolysis. 
 Only 2 of the 42 sterol metabolic enzymes were present 
in all the analyzed proteomes: geranyl/farnesyl diphos-
phate synthase (enzyme nos. 17 and 20, respectively). 
Thus, our proteome-wide profi ling approach indicates 
that the synthesis of farnesylpyrophosphate is essential to 
all eukaryotes and that farnesylpyrophosphate is a metabo-
lite of central importance to organisms, whether they use 
the MEV or the MEP/DOXP pathway. A possible explana-
tion is that farnesylation and geranylation of proteins is 
essential to eukaryotes. This hypothesis is in agreement 
with the fact that farnesyltransferases (EC 2.5.1.29, 2.5.1.58, 
and 2.5.1.60) occur in all the analyzed eukaryotes as deter-
mined with a profi le search analogous to those for sterol 
biosynthetic enzymes (data not shown). 
 Hierarchical clustering reveals convergent evolution 
 To detect less obvious and possibly new relationships 
regarding sterol metabolism of eukaryotes, we subjected 
the sterol metabolic profi les ( Fig. 2 ) to hierarchical 
clustering. Every analyzed species was represented by a 
42-tuple vector consisting of the best scores of the re-
spective proteome to each profi le. Hierarchical cluster-
ing of these vectors produced the “sterol biosynthesis 
tree” shown in  Fig. 3 ,  which basically subdivided the eu-
karyotes into species that make their own sterols (sterol 
prototrophs, left side) and species that do not (sterol 
auxotrophs, right side). The tree locally mirrored the 
phylogeny of the analyzed eukaryotes. The green plants 
analysis by implementing multiscale bootstrap resampling (n = 
10,000) to estimate “approximately unbiased” ( au ) errors, where 
 P = (100 –  au )/100. For principal component (PC) analysis we 
used basic R functions and  ggplot2 . The analyses were automated 
with Unix shell scripts and with Perl scripts. The phylogenetic 
trees were constructed from amino acid sequences with Mega 5, 
using the neighbor-joining algorithm and Jones-Taylor-Thornton 
substitution model. The number of bootstrap replications was 
1,000. 
 Gene expression 
 Tag counts of the sterol biosynthesis enzymes were extracted 
from three published  T. brucei short-read libraries (long slender 
bloodstream forms, short stumpy bloodstream forms, and procy-
clic tsetse fl y midgut forms) and from four  T. cruzi short-read li-
braries (intracellular amastigotes, trypomastigotes, epimastigotes, 
and metacyclics). The libraries had been produced by Illumina 
sequencing using the spliced-leader trapping (SLT) protocol 
( 32 ). Numbers of reads were normalized by using the DESeq 
( 33 ) bioconductor package. The gene expression data were mod-
eled with  prcomp as a numerical matrix of  M genes times  N librar-
ies. Eigenvalues and orthogonal eigenvectors were computed 
based on the square-symmetrical correlation matrix. 
 In vitro drug sensitivity 
 In vitro drug sensitivity assays were performed as described 
( 34–37 ). The tests were done over 72 h of incubation, except for 
the  T. cruzi assay, which lasted 96 h. For L6 cells,  L. donovani ,  T. 
brucei , and  G. intestinalis , the redox-sensitive dye resazurin (Ala-
mar Blue) served as an indicator of cell viability. For  P. falciparum , 
incorporation of  3 H-hypoxanthine was used. For  T. cruzi ,   -
galactosidase activity was quantifi ed with the substrate CPRG/
Nonidet. IC 50 values were estimated by linear interpolation based 
on the semilogarithmic dose-response curves. 
 RESULTS AND DISCUSSION 
 Sterol metabolic profi ling of eukaryote genomes 
 Aiming for a broad overview on sterol metabolism, we 
assembled a list of 42 relevant enzymes ranging from ter-
penoid backbone synthesis over squalene synthase to the 
formation of the different sterols and vitamin D derivatives 
as outlined in  Fig. 1 . For each enzyme, all the amino acid 
sequences that had been annotated in the manually cu-
rated section of UniProt with the corresponding EC num-
ber were retrieved ( Table 1 ). Each of these sequence sets 
was redundancy reduced to 90%. Then a ClustalW multi-
ple alignment was performed and converted to a position-
dependent scoring matrix with  hmmbuild of HMMer 3.0. 
The resultant 42 profi les were concatenated to a hidden 
Markov model (HMM) library for terpenoid backbone 
and sterol biosynthetic enzymes. This library was used for 
an in silico screen of eukaryote proteomes. For each pro-
teome and each enzyme, we retrieved the profi le-alignment 
score of the protein that had returned the lowest expec-
tancy ( E ) value. This approach allowed organizing the data 
in an unbiased, quantitative way, by plotting the obtained 
high scores as a two-dimensional heat map where the hori-
zontal cross-sections represent the “sterol biosynthetic 
profi le” of a given organism ( Fig. 2 ).  
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species located on the sterol prototrophic arm of the 
tree ( Fig. 3 ). 
 What is the origin of trypanosomatid ergosterol synthesis? 
 The sterol biosynthesis tree ( Fig. 3 ) is based on func-
tional predictions and cannot serve for phylogenetic mod-
els. To investigate the evolutionary origin of the sterol 
biosynthetic genes in trypanosomatids, we constructed 
phylogenetic trees for two key enzymes of ergosterol syn-
thesis: lanosterol 14  -demethylase (enzyme no. 24 in 
 Table 1 ), the target of azoles, and sterol 24-C-methyltrans-
ferase (enzyme no. 37), the dedicative enzyme for ergos-
terol synthesis. Both trees had a similar topology (except 
that sterol 24-C-methyltransferase does not occur in ani-
mals) with distinct branches for the major groups of eu-
karyotes and a highly signifi cant separate branch for the 
included trypanosomatid sequences ( Fig. 4 ). It was impos-
sible to root the trees because there are no suitable out-
groups for the two enzymes such as orthologs from 
bacteria. Acquisition of foreign genes by trypanosomes 
from plants has been suggested for glycosomal enzymes of 
 T. brucei ( 44, 45 ). The phylogenetic trees of lanosterol 14  -
demethylase and sterol 24-C-methyltransferase clearly do 
not support such a scenario for the sterol biosynthetic 
enzymes. Based on this bioinformatic analysis, one would 
exclude horizontal transfer as the evolutionary origin of 
trypanosomatid ergosterol synthesis. 
cosegregated, as did the trypanosomatids, the protos-
tomes, and the deuterostomes where the sea urchin 
 Strongylocentrotus purpuratus clearly clustered with the 
chordates. The fungi formed a cluster except for  E. cuniculi , 
and the apicomplexans formed a cluster except for  C. par-
vum . These two outliers segregated with  G. lamblia and 
 E. histolytica in a phylogenetically diverse branch of ami-
tochondriates ( Fig. 3 ). The analyzed ciliates clustered 
with the insects; however, this association was not sig-
nifi cant, and clearly, a larger number of ciliate genomes 
would be desirable to better resolve their position in the 
sterol biosynthesis landscape. 
 We interpret cases where clustering based on sterol 
biosynthesis enzymes does not coincide with eukaryote 
phylogeny as indicative of convergent evolution. Thus, 
the amoebazoon  Entamoeba and the fungus  Encephalito-
zoon , both obligate endoparasites, clustered together on 
the sterol-auxotrophic branch of the tree, whereas the 
free-living amoebazoa  D. discoideum and  P. palladium 
segregate on the sterol-prototrophic branch together 
with the free-living, or facultative parasitic, fungi ( Fig. 3 ). 
A likely explanation of this clustering is that the eukary-
ote progenitor synthesized sterols de novo, whereas the 
obligate endoparasites independently lost the corre-
sponding genes in adaptation to a parasitic lifestyle. 
The trypanosomatids are a notable exception: of all 
the included obligate endoparasites, they were the only 
 Fig.  2. Sterol biosynthetic profi les. The heat map denotes the best scores achieved by each proteome (rows, n = 46) against each profi le 
for a sterol biosynthetic enzyme (columns, n = 42). See  Table 1 for enzyme name and  Fig. 1 for its position in the pathway. 
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embryonic fi broblast and also against lovastatin, with the 
same result: IC 50 values clearly below 1 µM. Apparently, 
cholesterol synthesis was essential under our test condi-
tions. Tiludronate was inactive against all the tested cells. 
The most potent compound against  T. cruzi was ketocon-
azole, followed by simvastatin, which also showed a moder-
ate activity against  T. brucei (IC 50 = 4.6 µM) and  L. donovani 
(IC 50 = 4.7 µM). The activity against  T. cruzi was not con-
clusive due to the toxicity of simvastatin to L6 host cells 
(hence the parentheses in Table 2). Terbinafi ne, keto-
conazole, and fenpropimorph were moderately active 
 Susceptibility of parasites to SBIs 
 Given the antichagasic potential of azoles, we tested a 
panel of further known inhibitors of sterol biosynthesis, as 
indicated in  Fig. 1 , against parasites ( P. falciparum ,  L. dono-
vani ,  T. cruzi ,  T. brucei , and  G. lamblia ) and mammalian 
cells (rat L6 myoblasts). IC 50 values were determined in 
vitro ( Table 2 ).  As expected, the mammalian cells were 
rather tolerant to most of the tested drugs, except for sim-
vastatin, which had an IC 50 of 0.70 µM against the L6 cells. 
This result was surprising because simvastatin is widely 
used as a cholesterol-lowering agent. We also tested mouse 
 Fig.  3. Sterol biosynthetic tree of eukaryotes. The numerical vectors (rows of  Fig. 2 ) were clustered based on Canberra distance and the 
McQuitty algorithm. Gray numbers are “approximately unbiased” errors ( au ), where  P = (100    au )/100. 
 Fig.  4. Phylogenetic trees of key enzymes. Neighbor-joining trees of sterol 14-demethylase (enzyme no. 
24), the target of azoles (A), and sterol 24-C-methyltransferase (enzyme no. 37), the dedicative enzyme of 
ergosterol synthesis (B). The scale bars indicate number of substitutions per site. 
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correlated with PC-2 ( Fig. 6 ). Taken together, PC analysis 
of the steady-state expression levels of sterol biosynthetic 
genes singled out the insect stages of  T. brucei as well as 
 T. cruzi ( Fig. 6 ), demonstrating parallel metabolic adapta-
tions in African and South American trypanosomes. 
 CONCLUSION 
 Starting from the assumption that sterol synthesis is 
intrinsically linked to the evolution of eukaryotes, we per-
formed comparative genomics based on the profi ling 
of sterol biosynthetic enzymes ( Fig. 1 ). The aim was to in-
vestigate convergent evolution in eukaryotes and possibly 
link this to chemotherapeutic strategies against parasites. 
We refrained from functionally annotating the analyzed 
against  P. falciparum with IC 50 below 10 µM. Terbinafi ne 
was the only tested compound that showed a considerable 
effect on  Giardia (IC 50 = 0.62 µM). However, terbinafi ne 
inhibits squalene monooxygenase (enzyme no. 22), an en-
zyme that is absent in  Giardia ( Fig. 2 ). Comparing the in 
silico data of  Fig. 2 with the in vitro data of  Table 2 , we 
would expect a negative correlation between the score of 
the profi le search for a given enzyme and species and the 
IC 50 of a known inhibitor of the same enzyme. As shown in 
 Fig. 5 ,  this was the case with simvastatin (Spearman rank 
order correlation coeffi cient  r S =   0.89,  P < 0.05). For 
other compound-target pairs, there was either no correla-
tion (ketoconazole and sterol 14-demethylase,  r S = 0.06) or 
a positive, albeit nonsignifi cant, correlation (tiludronate 
and farnesyl diphosphate synthase,  r S = 0.31; fenpropi-
morph and lathosterol oxidase,  r S = 0.64). For terbinafi ne 
and its presumed target squalene epoxidase (enzyme no. 
22), there was even a signifi cant positive correlation be-
tween profi le score and IC 50 ( r S = 0.89,  P < 0.05;  Fig. 5 ). 
 Stage-specifi c regulation of sterol biosynthetic enzymes 
in trypanosomes 
 A possible reason for the lack of correlation between ge-
nomic makeup and drug susceptibility is that a particular 
target enzyme may be differently expressed across the life-
cycle stages of a parasite. We investigated the expression of 
sterol biosynthetic enzymes at the mRNA level in the try-
panosomatids  T. brucei and  T. cruzi using previously pub-
lished SLT data. SLT takes advantage of the conserved 
miniexon that is spliced in  trans to all trypanosomal mRNA 
( 46 ). We analyzed data from different stages of  T. brucei 
(slender bloodstream form, stumpy bloodstream form, and 
procyclic tsetse-midgut form) and  T. cruzi (intracellular 
amastigote form, trypomastigote form, and epimastigote tri-
atomine-midgut form) ( 32, 47 ). For both species, we found 
marked differences between the life-cycle stages regarding 
the steady-state expression levels of sterol biosynthetic genes. 
Generally, we detected higher mRNA levels of genes in-
volved in sterol biosynthesis in the insect stages than in the 
mammalian stages of the organisms. This is in good agree-
ment with the availability of sterols for the parasite in a mam-
malian host. PC analysis was performed for genes with 
orthologs in both species (n = 31). Plotting the fi rst two PCs 
revealed the proliferating insect stages of both  T. brucei and 
 T. cruzi to more closely align with PC-2 than with PC-1, and 
to positively correlate with either PC ( Fig. 6 ).  In contrast, the 
proliferating mammalian stages, as well as all the nonprolif-
erating stages, more closely aligned with PC-1 and oppositely 
 TABLE 2. Sensitivity a of mammalian cells b and parasites c to sterol antimetabolites 
L6 Pfa Ldo Tcr Tbr Gla
Simvastatin 0.70 28.43 4.66 (1.78 ) 4.58 45.20
Tiludronate 204.00 21.04 119.07 169.82 120.66 64.22
Terbinafi ne 40.59 6.07 15.95 21.32 88.45 0.62
Ketoconazole 22.25 4.01 28.93 0.01 26.28 10.67
Fenpropimorph 33.59 3.22 35.60 8.95 25.18 4.88
 a IC 50 in µM.
 b L6 rat skeletal muscle cells.
 c Gla,  G. lamblia , Ldo,  L. donovani ; Pfa,  P. falciparum ; Tbr,  T. brucei ; Tcr,  T. cruzi .
 Fig.  5. Correlation of genotype and phenotype. For each species, 
the in vitro IC 50 (in µM) of the drugs simvastatin (A) and terbin-
afi ne (B) is plotted versus the highest score attained of the species’ 
proteome against the HMM profi le of the presumed target of that 
drug. Gla,  G. lamblia ; L6, rat L6 myoblasts; Ldo,  L. donovani ; Pfa, 
 P. falciparum ; Tbr,  T. brucei ; Tcr,  T. cruzi . 
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which belong to the amoebozoa but have been proposed 
to have algal ancestry based on their capability to synthe-
size cycloartenol ( 6 ). An unrooted phylogenetic tree of 
sterol 24-C-methyltransferase ( Fig. 4 ) did not shed light 
on the ancestry of the enzyme (it was not possible to root 
the tree due to the lack of an ortholog from prokaryotes 
to use as an outgroup). The main conclusion from the 
phylogenetic analysis is that there is no evidence for hori-
zontal transfer as the origin of sterol biosynthetic genes in 
trypanosomatids. 
 Apart from their enigmatic history, a major question 
brought forward by the sterol biosynthetic enzymes of try-
panosomatids is to what extent they are exploitable for 
chemotherapy. Azoles are in development as antichagasic 
agents because they exhibit selective activity against  T. 
cruzi . Their target is sterol 14-demethylase (enzyme no. 
24), and in a phylogenetic tree of the enzyme, the trypano-
somatid orthologs form a clearly distinct branch ( Fig. 4 ). 
We tested other known inhibitors of sterol biosynthesis 
against trypanosomatids and other parasites ( Table 2 ). In 
general, the in vitro activity of the inhibitors did not cor-
relate with the presence of their presumed target enzyme 
( Fig. 5 ). Although the activity of ketoconazole against  T. 
cruzi was unmatched, simvastatin also showed activity against 
trypanosomatids. However, the results were not conclusive 
because, surprisingly, simvastatin was toxic to mammalian 
cell lines even though it is widely used as a cholesterol-
lowering drug. Furthermore, simvastatin was successfully 
used for the treatment of mouse ( 49 ) and dog ( 50 ) models 
of Chagas’s disease. 
 Comparing the stage-specifi city of expression of the ste-
rol biosynthetic enzymes in  T. brucei and  T. cruzi revealed 
interesting parallels. The sterol metabolic enzymes were 
differentially regulated across the different life stages, and 
the expression patterns were similar for both species. The 
proteomes because our in silico pipeline did not furnish 
proof of function. It provided quantitative scores for all 
enzymes and proteomes ( Fig. 2 ), which lent itself for clus-
tering. The resulting tree’s principal subdivision was be-
tween the sterol-prototrophs and the sterol-auxotrophs 
( Fig. 3 ). The latter included all of the analyzed protos-
tomes, the former the deuterostomes (i.e., the vertebrates 
plus the sea urchin  S. purpuratus ). 
 The interesting branches of the sterol metabolic tree 
were those where the grouping deviated from evolution-
ary descent. This was observed for unicellular obligate en-
doparasites, which appeared to have independently lost 
genes for sterol biosynthetic enzymes, presumably in adap-
tation to a parasitic lifestyle. Thus, the microsporidian 
 Encephalitozoon did not group with the free-living and fac-
ultative parasitic fungi but with parasitic protozoa such 
as  Giardia . The same was observed for  Entamoeba , which 
did not group with the free-living amoebozoa but with the 
apicomplexan  Cryptosporidium . In fact, both  Entamoeba and 
 Cryptosporidium exhibited extreme cases of metabolic re-
duction, lacking the sterol biosynthetic enzymes as well as 
either pathway, MEV or non-MEV, for isoprenoid synthe-
sis. The only enzymes present in all the analyzed proteomes 
were the farnesyl/geranyl diphosphate synthases and the 
protein farnesyl transferase complex, indicating that pro-
tein prenylation is indispensable to all eukaryotes. 
 The only obligate endoparasites that possessed sterol 
biosynthetic genes were the trypanosomatids,  Trypanosoma 
spp. and  Leishmania spp. ( Fig. 2 ). Ergosterol has long been 
known to occur in trypanosomatids ( 48 ), and all the ana-
lyzed species scored positive for the key enzyme in ergos-
terol synthesis, sterol 24-C-methyltransferase (enzyme no. 
37 in  Figs. 1 and 2 and  Table 1 ). In the sterol metabolic 
tree of  Fig. 3 , all the trypanosomatids grouped together, 
sister to the slime molds  Dictyostelium and  Polysphondylium , 
 Fig.  6. Expression profi les in  Trypanosoma spp. Loading plots based on PC-1 and PC-2 of the steady-state mRNA levels of sterol biosyn-
thetic genes expressed in count per million. A:  T. brucei procyclic forms (PC) and long slender (LS) and short stumpy (SS) bloodstream 
forms. B:  T. cruzi epimastigotes (epi), metacyclics (meta), trypomastigotes (trypo), and amastigotes (ama). 
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bloodstream forms correlated positively with each other 
and negatively with the insect forms ( Fig. 6 ). The expres-
sion levels of the sterol biosynthetic genes were generally 
higher in the insect stages than in the mammalian stages 
of both  T. cruzi and  T. brucei . Sterol 24-C-methyltransferase 
(enzyme no. 37) might be a good drug target because it is 
highly expressed and thus probably essential in all the life-
cycle stages. Finally, the trypanosomatids lacked the bona 
fi de genes for sterol esterifi cation ( Fig. 2 , enzyme nos. 33 
and 34), and yet they had been shown to build sterol esters 
( 43 ). Thus, we hypothesize that trypanosomatids possess 
atypical sterol ester synthase and esterase, which represent 
another possible point for chemotherapeutic interven-
tion. In summary, we conclude that sterol metabolism of-
fers further potential drug targets for selective inhibition 
of trypanosomes.  
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